Theranos Investor Conference Presentation Deck slide image

Theranos Investor Conference Presentation Deck

NAA Zika Assay: Clinical Study Overview Population Healthy or Zika symptomatic Sample type and matrix Capillary whole blood, venous serum, and urine Analyzers & assays Study design Analysis 20 miniLabs CDC RT-PCR assay altona RealStar® (EUA Authorized Method) FDA EUA guidance Compute negative and positive percent agreement compared to the comparative methods This technology has not been cleared or approved by the FDA and is not for sale in the United States. theranos 72
View entire presentation